Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-013591
Filing Date
2020-02-27
Accepted
2020-02-27 19:33:48
Documents
2
Period of Report
2020-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3107
2 POA DOCUMENT poa.txt EX-24.3_899022 3749
  Complete submission text file 0001209191-20-013591.txt   8324
Mailing Address C/O ALLOS THERAPEUTICS, INC. 11080 CIRCLEPOINT ROAD, SUITE 200 WESTMINSTER CO 80020
Business Address
Goldsmith Bruce A (Reporting) CIK: 0001500322 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39231 | Film No.: 20664915

Mailing Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103
Business Address TWO COMMERCE SQUARE 2001 MARKET STREET, 28TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)